Hellolife, Inc. Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination
If your email program has trouble displaying this email, view it as a web page |
U.S. Food and Drug Administration |
Comments
Post a Comment